Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
Journal of the American Academy of Dermatology | Sep 20, 2017
Condom use and incident sexually transmitted infection after initiation of long-acting reversible contraception
American Journal of Obstetrics and Gynecology | Sep 20, 2017
Most read this week